Gilder Gagnon Howe & CO LLC Provention Bio, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $85,165 - $199,159	18,842 New	18,842 $199,000
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $1.63 Million - $2.4 Million	-288,070 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $18.9 Million - $31.2 Million	-2,821,804 Reduced 90.74%	288,070 $2.43 Million
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $7.59 Million - $14.6 Million	750,192 Added 31.79%	3,109,874 $32.6 Million
Q4 2020 Feb 16, 2021	BUY	$11.79 - $18.94 $2.46 Million - $3.94 Million	208,280 Added 9.68%	2,359,682 $40 Million
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $9.31 Million - $13.7 Million	900,142 Added 71.94%	2,151,402 $27.6 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $9.77 Million - $21.3 Million	1,251,260 New	1,251,260 $17.7 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.